Behavioral Health Screening in Military Cystic Fibrosis Centers: A Survey
Catherine Rutledge1, Christine Gould2, Paul C Lee3
1Department of Behavioral Health, Tripler Army Medical Center, Honolulu, HI 96859, USA.
Military Medicine
|June 30, 2022
Summary
Cystic fibrosis (CF) care in the DoD shows gaps in standardized suicidality screening and caregiver comfort. Improved use of the Behavioral Health Data Portal (BHDP) is recommended for better mental health support.
Area of Science:
- Medical Research
- Public Health
- Genetics
Background:
- Cystic Fibrosis (CF) is a life-threatening genetic illness with higher rates of depression and anxiety in patients and caregivers.
- Guidelines recommend regular behavioral health (BH) screening for CF patients and caregivers.
- This study assesses BH care within the Department of Defense (DoD) healthcare system for CF patients.
Purpose of the Study:
- To characterize the current state of BH care in routine CF treatment within the DoD.
- To identify areas for improvement in BH screening and support for CF patients and their caregivers.
- To inform future research on mental health in CF care.
Main Methods:
- A web-based survey was administered to 8 program leaders (directors and nurse coordinators) across 6 DoD CF centers.
- The survey assessed screening tools, BH team composition, provider comfort levels, and familiarity with the BHDP.
- The study design was descriptive and approved by the Tripler Army Medical Center Human Use Committee.
Main Results:
- 80% of centers screen patients 12+ and caregivers annually for depression and anxiety using specific tools.
- Suicidality screening tools were not standardized; social workers were present in all clinics.
- Providers reported moderate comfort screening patients but low comfort screening caregivers; 80% were unaware of or not using the BHDP.
Conclusions:
- Routine BH care in DoD CF centers needs standardized suicidality screening and increased provider comfort.
- Streamlining data recording and tracking via the BHDP is crucial for improved BH care.
- Addressing these areas can enhance mental health support for CF patients and caregivers and aid future research.
Related Concept Videos
01:24Cystic Fibrosis: Management
220
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
220
01:23Cystic Fibrosis: Pathogenesis
357
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
357
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
01:28Physical Assessment of the Respiratory Tract I: Health History
386
Physical assessment of the respiratory tract is critical to patient care. It allows healthcare professionals to identify and manage various respiratory conditions. The process involves a combination of subjective and objective data collection.
Subjective Data
Subjective data provides vital information about the patient's health history and symptoms. This data is typically collected through interviews in which patients describe their experiences, symptoms, and concerns.
Health history and...
Subjective Data
Subjective data provides vital information about the patient's health history and symptoms. This data is typically collected through interviews in which patients describe their experiences, symptoms, and concerns.
Health history and...
386
01:25Pulmonary Function Tests
431
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
431